An International Conference on Advances in Radiation Oncology will give attendees the opportunity to dive into the future of radiation oncology. This international forum brings together leading clinicians and specialists from around the globe to explore groundbreaking innovations in technology, medical physics and molecular biology – all through the lens of patient-centred care.
Participants will have the chance to engage in thought-provoking discussions, network with industry pioneers, and gain insights into the latest advancements that are reshaping the field. From cutting-edge treatment methods to the integration of new technologies, the International Conference on Advances in Radiation Oncology (ICARO-4) promises to inspire and equip conference attendees with the knowledge to enhance their practice.
The IAEA invites interested participants to submit abstracts for its upcoming conference which will be held in Vienna, Austria from 2 to 5 June 2025. Abstracts must be submitted by 25 November at the latest.
There have been a number of advances in radiotherapy in recent years, including: stereotactic radiotherapy, intensity modulated radiation therapy, image-guided radiation therapy, motion management techniques, magnetic resonance imaging-guided linear accelerators, three-dimensional conformal brachytherapy, proton therapy and light ion therapy, to name but a few. However, access to high standard cancer care remains a global challenge.
The increased use of these complex tools and techniques – coupled with the need to address a growing cancer burden by treating more patients in less time – continues to drive countries’ reliance on high-end technologies. For health care programmes, providers and patients alike, these technologies can impose a financial burden. At the same time, countries also face challenges in developing and implementing quality assurance programmes for these techniques.
ICARO-4 will provide the platform:
- to survey the status of evidence-based treatment recommendations for common cancers; latest developments in medical dosimetry and dose auditing procedures; and resource sparing approaches.
- to explore the applications of improved imaging tools for treatment planning along with future directions in the clinical use of radiotherapy.
Through in-depth discussions and interactive sessions, participants will be able to exchange scientific knowledge and best practices to implement technological advances in line with the needs and preferences of their patients.
Radiation oncologists, radiation biologists, medical physicists, radiation therapists as well as scientists, researchers and biomedical engineers within the field of radiotherapy are all invited to submit academic and practice-based contributions within the following topics:
- Technological advances and challenges
- Roadmaps for setting up modern radiation oncology facilities
- New treatment and imaging techniques and clinical evidence
- Health economics in radiotherapy
- Developments in treatment planning
- Dosimetry
- Auditing procedures
- Personalized medicine
- Advances in the treatment of recurrent patients
- National cancer control strategies
- Developments in quality assurance and new approaches to quality management
- Safety in radiation therapy
- Intensity modulated radiotherapy, including arc-based approaches
- Image-guided radiotherapy, including MRI guided
- Stereotactic radiotherapy
- Proton and light ion therapy
- Telemedicine
- Radiation biology
- Spatially fractionated radiation therapy
- FLASH therapy
- Combined therapies
- Paediatric radiotherapy
- Clinical research
- Applied brachytherapy
- Education and training of professionals.
Abstracts should be of approximately 150 to 200 words and can only be submitted electronically through IAEA-INDICO. All guidance for uploading abstracts is available under ICARO-4 conference webpage.
Conference participants will be awarded an appropriate number of accredited Continuing Medical Education credits.
ICARO-4 follows the success of ICARO-1 in 2009, ICARO-2 in 2017 and ICARO-3 in 2021.
